R&D Systems Recombinant Human AS3MT Protein CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems 9827MT050
DescriptionThe Recombinant Human AS3MT Protein is derived from E. coli. The Recombinant Human AS3MT Protein has been validated for the following applications: Bioactivity.
|Lyophilized from a 0.2μm filtered solution in Tris and NaCl with Trehalose.|
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.|
|<0.10 EU per 1μg of the protein by the LAL method.|
|arsenic (+3 oxidation state) methyltransferase, Arsenic Methyltransferase, arsenite methyltransferase, CYT19, CYT19methyltransferase cyt19, EC 126.96.36.199, Methylarsonite methyltransferase, Methyltransferase Cyt19, S-Adenosyl-L-Methionine:Arsenic(III) Methyltransfe, S-adenosyl-L-methionine:arsenic(III) methyltransferase, S-Adenosylmethionine:Arsenic (III) Methyltransfera, S-adenosylmethionine:arsenic (III) methyltransferase|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|Reconstitute at 500μg/mL in water.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok